Relation between tumor size, quality of life, and survival in patients with colorectal liver metastases

Journal of Clinical Oncology

Volumn 14, Issue 1, 1996, Pages 171-175

  Earlam, S ^a   Glover, C ^a   Fordy, C ^a   Burke, D ^a   Allen Mersh, T G ^a  

^a CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL FEATURE; COLORECTAL CANCER; DIARRHEA; FEEDING DISORDER; HUMAN; LIVER METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; RESTLESSNESS; SLEEP DISORDER; SURVIVAL TIME; TUMOR VOLUME;

EID: 0030050778     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1996.14.1.171     Document Type: Article

References (23)

1. Dworkin M, Burke D, Earlam S, et al: Measurement of response to treatment in colorectal liver metastases. Br J Cancer 71:873-876, 1995
2. Maguire P, Selby P: Assessing quality of life in cancer patients. Br J Cancer 60:437-440, 1989
3. Ruckdeschel JC, Piantodosi S: Quality of life assessment in lung surgery for bronchogenic carcinoma. J Theoret Surg 6:201-205, 1991
4. Coates A, Gebski V, Signoriri D, et al: Prognostic value of quality of life scores during chemotherapy for advanced breast cancer. J Clin Oncol 12:1833-1838, 1992
5. Tannock IF: Some problems related to the design and analysis of clinical trials. Int J Rad Oncol 22:881-885, 1992
6. Purkiss SF, Williams NS: Growth rate and percentage hepatic replacement of colorectal liver metastases. Br J Surg 80:1036-1038, 1993
7. Allen-Mersh TG: Improving survival after large bowel cancer. Br Med J 303:595-596, 1991
8. O'Neill WM: Pain in malignant disease. Prescribers J 33:250-258, 1993
9. Bergner M, Bobbitt RA, Carter WB, et al: The Sickness Impact File: Development and final revision of a health status measure. Medcare 19:787-905, 1981
10. DeHaes IC, Van Knippenberg FC, Neijt JP: Measuring psychological and physical distress in cancer patients: Structure and application of the Rotterdam Symptom Checklist. Br J Cancer 62:1034-1038, 1990
11. Zigmund AS, Snaith RP: The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 67:361-370, 1983
12. Kaplan EL, Meier P: Nonparametric estimations for incomplete observations. J Am Stat Assoc 53:457-481, 1958
13. Peto R, Pike MC, Armitage P, et al: Design and analysis of randomised clinical trials requiring prolonged observations. Br J Cancer 35:1-39, 1977
14. Dixon W: Bivariate scatter plots, in BMDP Statistical Software Manual, Release 7. Los Angeles, CA, University of California, pp 188-199
15. Dixon W: Stepwise Regression, in BMDP Statistical Software Manual, Release 7. Los Angeles, CA, University of California, 1992, pp 387-423
16. Allen-Mersh TG, Earlam S, Fordy C, et al: Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases. Lancet 344:1255-1260, 1994
17. Rougier P, Laplanche A, Hugier M: Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: Long-term results of a prospective randomized trial. J Clin Oncol 10:1112-1118, 1992
18. Stangle R, Altendorf-Hofmann A, Charnley R, et al: Factors influencing the natural history of colorectal liver metastases. Lancet 343:1405-1410, 1994
19. Miller D, Nott K, Vedhara K: HIV and psychoimmunology: Evidence promising and forthcoming. J R Soc Med 87:687-690, 1994
20. Preston T, Fearon K, McMillan C, et al: Effect of ibuprofen on the acute-phase response and protein metabolism in patients with cancer and weight loss. Br J Surg 82:229-234, 1995
21. Bunn P, Minna J: Paraneoplastic syndromes, in De Vita VT, Hellman S, Rosenberg RA (eds): Cancer, Principles and Practice of Oncology (ed 4). Philadelphia, PA, Lippincott, 1985, pp 2025-2058
22. Allen-Mersh TG: Improving palliation for patients with gastrointestinal cancer. Br J Surg 81:86, 1994
23. Dworkin MJ, Allen-Mersh TG: Regional infusion chemotherapy for colorectal hepatic metastases - Where is it going? Cancer Treat Rev 18:213-224, 1991